Exogenous surfactant in the late respiratory phase of COVID-19
The article presents data on the course of inhalations with a native surfactant administered in two patients (66 and 53 years old) at the late respiratory phase of the new coronavirus infection of COVID-19 (the 22nd and the 19th days from the disease onset) who received non-invasive artificial lung...
Saved in:
| Main Authors: | K. G. Shapovalov, S. А. Lukyanov, V. А. Konnov, O. А. Rozenberg |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2021-06-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1534 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surfactant therapy in developing severe respiratory insufficiency in tuberculosis patients with concurrent HIV infection
by: E. A. Borodulina, et al.
Published: (2016-01-01) -
Characterization of atomization and delivery efficiency of exogenous surfactant in preterm infant lungs using an ex vivo respiratory model
by: Ghalia Kaouane, et al.
Published: (2025-05-01) -
Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part I)
by: O. A. Rozenberg
Published: (2014-08-01) -
Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01) -
Bronchoscopic lung lavage and exogenous surfactant successfully reverse respiratory failure after severe chlorine exposure: A pediatric case report
by: Paola Papoff, et al.
Published: (2025-01-01)